Airway Prevotella enhance innate immune-mediated protection against lung infection

气道普雷沃氏菌增强先天免疫介导的肺部感染保护

基本信息

  • 批准号:
    10561450
  • 负责人:
  • 金额:
    $ 49.17万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-03-20 至 2028-02-29
  • 项目状态:
    未结题

项目摘要

Project Summary These studies address the large gap in knowledge regarding how commensal bacteria in the airway protect against bacterial pneumonia. Next generation sequencing studies of the airway microbiome have revealed that specific respiratory bacteria are associated with a reduced abundance of Streptococcus pneumoniae, a major cause of bacterial pneumonia, indicating a potentially protective role. A long-term goal of this work is to reduce the burden of pneumonia by optimizing protection mediated by `beneficial' airway commensals. This project will advance this goal by addressing how a prominent respiratory bacterium influences immune-mediated clearance of S. pneumoniae from the lung. For this purpose, we developed an animal model that recapitulates the relationship between one of the most abundant bacteria detected in the lung, Prevotella melaninogenica, and lung infection with S. pneumoniae. Preliminary data indicate that exposure to P. melaninogenica dramatically improves early clearance of S. pneumoniae from the lung. This effect requires neutrophils, the innate immune receptor TLR2, and the production of pro-inflammatory cytokines, including TNFα. Neutrophils purified from the lungs of P. melaninogenica-exposed mice express TLR2-dependent TNFα and are more effective at killing S. pneumoniae. Further, digestion of P. melaninogenica lipoproteins, which are recognized by TLR2, is associated with loss of protection and TNFα expression, highlighting key roles for these molecules. Finally, regulation of P. melaninogenica-induced inflammation by the anti-inflammatory cytokine IL-10 restrains the TNFα-associated inflammatory response within 24 hours and is important for effective S. pneumoniae clearance. These data support the overall hypothesis that P. melaninogenica serves complementary roles to protect against S. pneumoniae infection by 1) inducing an innate immune response characterized by TLR2-dependent activation of neutrophils, which enhances rapid clearance of S. pneumoniae from the lung, while 2) supporting IL-10 dependent abrogation of infection-associated inflammatory damage. To address this hypothesis, Aim 1 investigates host factors required for enhanced S. pneumoniae killing, including alveolar macrophages, neutrophil TNFα signaling, and baseline immune priming by the endogenous microbiota. Aim 2 evaluates how lipoprotein-TLR2 signaling intersects with other Prevotella ligand-TLR interactions and addresses the generalizability of the protective effect by comparison with other Prevotella species. In Aim 3, lung cellular infiltration, activation and pathology will be assessed over the course of S. pneumoniae co-infection in mice with deficiencies in IL-10 or myeloid cell IL-10R to determine the kinetics and cellular targets of P. melaninogenica-induced, IL-10-mediated control of inflammation and injury. Together, these studies provide a mechanistic pathway to investigate the microbiome-lung axis in order to guide the development of new strategies to improve airway commensal-mediated protection in vulnerable populations.
项目摘要 这些研究解决了关于呼吸道中的细菌如何预防细菌性肺炎的知识的巨大空白。对气道微生物组的下一代测序研究表明,特定的呼吸道细菌与肺炎链球菌(细菌性肺炎的主要原因)丰度降低有关,这表明了潜在的保护作用。这项工作的一个长期目标是通过优化“有益的”气道呼吸系统介导的保护来减轻肺炎的负担。这个项目将通过解决一个突出的呼吸道细菌如何影响免疫介导的S。肺炎从肺部。为此,我们开发了一种动物模型,该模型概括了肺中检测到的最丰富的细菌之一,产黑色素普雷沃氏菌和肺感染S。肺炎。初步数据表明,暴露于P. melaninogenica显着提高早期清除S。肺炎从肺部。这种作用需要中性粒细胞、先天免疫受体TLR 2和促炎细胞因子(包括TNFα)的产生。从暴露于黑色素原杆菌的小鼠的肺中纯化的中性粒细胞表达TLR 2依赖性TNFα,并且在杀死S.肺炎。此外,由TLR 2识别的黑色素原卟啉单胞菌脂蛋白的消化与保护和TNFα表达的丧失相关,突出了这些分子的关键作用。最后,通过抗炎细胞因子IL-10调节黑色素原卟啉单胞菌诱导的炎症,在24小时内抑制了TNFα相关的炎症反应,这对有效的S.肺炎清除率。这些数据支持了黑色素原杆菌在抵抗沙门氏菌中起补充作用的总体假设。肺炎链球菌感染通过1)诱导以嗜中性粒细胞的TLR 2依赖性活化为特征的先天性免疫应答,其增强对肺炎链球菌的快速清除。2)支持IL-10依赖性消除感染相关的炎性损伤。为了解决这一假设,目的1调查宿主因素所需的增强S。pneumoniae杀伤,包括肺泡巨噬细胞、中性粒细胞TNFα信号传导和内源性微生物群的基线免疫启动。目的2评估脂蛋白-TLR 2信号传导如何与其他普雷沃氏菌配体-TLR相互作用交叉,并通过与其他普雷沃氏菌属物种的比较来解决保护作用的普遍性。在目标3中,将在S.本发明的目的是在具有IL-10或髓样细胞IL-10 R缺陷的小鼠中检测肺炎链球菌共感染的细胞因子,以确定黑色素原卟啉单胞菌诱导的IL-10介导的炎症和损伤控制的动力学和细胞靶标。总之,这些研究提供了一种机制途径来研究微生物组-肺轴,以指导新策略的开发,从而改善易感人群中气道炎症介导的保护作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sarah E Clark其他文献

Combined Epigenetic Therapy to Induce Latency II/III Antigen Expression in Latency I EBVsup+/sup Lymphoma
联合表观遗传疗法诱导潜伏 I 型 EB 病毒阳性淋巴瘤中的潜伏 II/III 抗原表达
  • DOI:
    10.1182/blood-2024-201570
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
    23.100
  • 作者:
    Isabella Y Kong;Sarah E Clark;Suhong Sun;Vicenta Trujillo-Alonso;Alicia Alonso;Roberta Zappasodi;Ethel Cesarman;Lisa Giulino Roth
  • 通讯作者:
    Lisa Giulino Roth
Combined Epigenetic Therapy to Induce Latency II/III Antigen Expression in Latency I EBV<sup>+</sup> Lymphoma
  • DOI:
    10.1182/blood-2024-201570
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
  • 作者:
    Isabella Y Kong;Sarah E Clark;Suhong Sun;Vicenta Trujillo-Alonso;Alicia Alonso;Roberta Zappasodi;Ethel Cesarman;Lisa Giulino Roth
  • 通讯作者:
    Lisa Giulino Roth
Contextual assessment of the breadth and level of investments made by prevention initiatives to improve nutrition and prevent obesity in Los Angeles County, 2010–2015
对 2010-2015 年洛杉矶县改善营养和预防肥胖的预防举措的投资广度和水平的背景评估
  • DOI:
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    2.8
  • 作者:
    Katherine Sutton;Sarah E Clark;Jack Thompson;Lisa Craypo;Liz Schwarte;T. Kuo
  • 通讯作者:
    T. Kuo
Insights into the role of the respiratory tract microbiome in defense against bacterial pneumonia
对呼吸道微生物组在抵御细菌性肺炎中作用的深入洞察
  • DOI:
    10.1016/j.mib.2024.102428
  • 发表时间:
    2024-02-01
  • 期刊:
  • 影响因子:
    7.500
  • 作者:
    Zoe G Drigot;Sarah E Clark
  • 通讯作者:
    Sarah E Clark

Sarah E Clark的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sarah E Clark', 18)}}的其他基金

Host factors influencing early clearance of Streptococcus pneumoniae from the middle ear following invasion from the nasopharynx
影响肺炎链球菌从鼻咽部侵入后中耳早期清除的宿主因素
  • 批准号:
    10551220
  • 财政年份:
    2022
  • 资助金额:
    $ 49.17万
  • 项目类别:
Host factors influencing early clearance of Streptococcus pneumoniae from the middle ear following invasion from the nasopharynx
影响肺炎链球菌从鼻咽部侵入后中耳早期清除的宿主因素
  • 批准号:
    10358434
  • 财政年份:
    2022
  • 资助金额:
    $ 49.17万
  • 项目类别:
Bacterial-driven immune suppression in the lung
肺部细菌驱动的免疫抑制
  • 批准号:
    10475452
  • 财政年份:
    2019
  • 资助金额:
    $ 49.17万
  • 项目类别:
Natural killer cell-derived IL-10 and immunity to Listeria
自然杀伤细胞衍生的 IL-10 和对李斯特菌的免疫力
  • 批准号:
    8975083
  • 财政年份:
    2014
  • 资助金额:
    $ 49.17万
  • 项目类别:
Natural killer cell-derived IL-10 and immunity to Listeria
自然杀伤细胞衍生的 IL-10 和对李斯特菌的免疫力
  • 批准号:
    8783266
  • 财政年份:
    2014
  • 资助金额:
    $ 49.17万
  • 项目类别:

相似海外基金

The role of alveolar macrophages and regulatory pathways in post-transplant lung inflammation.
肺泡巨噬细胞和调节途径在移植后肺部炎症中的作用。
  • 批准号:
    23K08315
  • 财政年份:
    2023
  • 资助金额:
    $ 49.17万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
MICA: Key mechanisms underlying inhaled GM-CSF's enhancement of phagocytosis and bacterial clearance by human alveolar macrophages.
MICA:吸入 GM-CSF 增强人肺泡巨噬细胞吞噬作用和细菌清除的关键机制。
  • 批准号:
    MR/X005046/1
  • 财政年份:
    2023
  • 资助金额:
    $ 49.17万
  • 项目类别:
    Research Grant
Analysis of pathogenic alveolar macrophages which release IL-1alpha in response to fine particles.
分析响应细颗粒物释放 IL-1α 的致病性肺泡巨噬细胞。
  • 批准号:
    23H03154
  • 财政年份:
    2023
  • 资助金额:
    $ 49.17万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Glutamine Metabolism in Alveolar Macrophages following Influenza A Infection
甲型流感感染后肺泡巨噬细胞的谷氨酰胺代谢
  • 批准号:
    10607319
  • 财政年份:
    2023
  • 资助金额:
    $ 49.17万
  • 项目类别:
The function and regulation of tissue resident alveolar macrophages turnover by host and environmental factors during homeostasis and in infections
稳态和感染期间宿主和环境因素对组织驻留肺泡巨噬细胞周转的功能和调节
  • 批准号:
    471247
  • 财政年份:
    2022
  • 资助金额:
    $ 49.17万
  • 项目类别:
    Fellowship Programs
Using a Lung on Chip Device to Study Alveolar Macrophages as Intracellular Reservoirs for Staphylococcus aureus
使用肺芯片装置研究肺泡巨噬细胞作为金黄色葡萄球菌的细胞内储库
  • 批准号:
    485971
  • 财政年份:
    2022
  • 资助金额:
    $ 49.17万
  • 项目类别:
    Studentship Programs
Analysis of innate immune response of alveolar macrophages and epithelial-mesenchymal transition of alveolar epithelial cells
肺泡巨噬细胞的先天免疫反应和肺泡上皮细胞的上皮间质转化分析
  • 批准号:
    22K06698
  • 财政年份:
    2022
  • 资助金额:
    $ 49.17万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Cholesterol crystal-mediated inflammation in alveolar macrophages: an emerging role inidiopathic lung fibrosis?
胆固醇晶体介导的肺泡巨噬细胞炎症:在特发性肺纤维化中的新兴作用?
  • 批准号:
    462596862
  • 财政年份:
    2021
  • 资助金额:
    $ 49.17万
  • 项目类别:
    WBP Position
Elucidation of idiopathic pneumonia syndrome: Angiotensin 2 activates alveolar macrophages
特发性肺炎综合征的阐明:血管紧张素 2 激活肺泡巨噬细胞
  • 批准号:
    21K16251
  • 财政年份:
    2021
  • 资助金额:
    $ 49.17万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Establishment of novel macrophage cell lines to study the pathogenesis of respiratory bacterial pathogens in lung alveolar macrophages
建立新型巨噬细胞系以研究肺泡巨噬细胞中呼吸道细菌病原体的发病机制
  • 批准号:
    NC/V001019/1
  • 财政年份:
    2021
  • 资助金额:
    $ 49.17万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了